Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Spinal Cord Injury ll: Pathophysiology

Spinal Cord Injury ll: Pathophysiology

Spinal cord injury progresses through two interconnected phases: primary injury and secondary injury.Primary InjuryPrimary injury happens at the moment of trauma and involves immediate mechanical damage to the spinal cord.Compression happens when broken vertebrae, herniated discs, or accumulating blood (such as a hematoma) press directly against the spinal cord, distorting its normal shape and function. In cases of contusion, the cord is bruised by a blunt force (like penetrating injuries or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Therapeutic Prospects in Preeclampsia - A Mini-Review.

Current medicinal chemistry·2019

Same author

Superior cervical ganglion mimicking retropharyngeal adenopathy in head and neck cancer patients: MRI features with anatomic, histologic, and surgical correlation.

Neuroradiology·2015

Same author

Neurotrophin-3 stimulates migration of mesenchymal stem cells overexpressing TrkC.

Current medicinal chemistry·2013

Same author

Combat-training increases intestinal permeability, immune activation and gastrointestinal symptoms in soldiers.

Alimentary pharmacology & therapeutics·2013

Same author

Hypoxia-induced retinal ganglion cell damage through activation of AMPA receptors and the neuroprotective effects of DNQX.

Experimental eye research·2013

Same author

Combustion smoke-induced inflammation in the cerebellum and hippocampus of adult rats.

Neuropathology and applied neurobiology·2012

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

Stem cell therapy for spinal cord injury.

E M Kan¹, E A Ling, J Lu

¹Combat Care Laboratory, Defence Medical and Environmental Research Institute, DSO National Laboratories, 27 Medical Drive, #12-00, Singapore 117510.

Current Medicinal Chemistry

|November 11, 2010

Summary

Stem cell therapy (SCT) offers potential for spinal cord injury (SCI) but faces challenges. Careful risk-benefit assessment and collaboration are crucial for safe and effective clinical application.

More Related Videos

Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury

Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury

Published on: April 12, 2024

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Published on: December 17, 2014

Related Experiment Videos

Last Updated: Jun 6, 2026

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury

Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury

Published on: April 12, 2024

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Published on: December 17, 2014

Area of Science:

Neuroscience
Regenerative Medicine
Biotechnology

Background:

Spinal cord injury (SCI) causes permanent neurological deficits by damaging axons and disrupting myelination.
Current treatments for SCI offer limited recovery, leaving patients with chronic disabilities.
Stem cell biology advancements provide potential therapeutic strategies for SCI.

Purpose of the Study:

To review the advantages and disadvantages of different stem cell types for SCI.
To identify barriers hindering the translation of stem cell therapy from animal models to human clinical trials.
To emphasize the need for standardized clinical trial guidelines and realistic expectations for stem cell therapy in SCI.

Main Methods:

Literature review of stem cell strategies for SCI.
Analysis of preclinical and clinical trial data.
Discussion of translational challenges and regulatory considerations.

Main Results:

Various stem cell types (embryonic, adult neural, induced pluripotent) show promise but have limitations.
Significant barriers exist in translating animal research findings to human SCI treatments.
Clinical trials for SCT in SCI are limited, with ongoing evaluation of safety and efficacy.

Conclusions:

Stem cell therapy for SCI requires careful management of expectations, avoiding portrayals as a definitive cure.
Successful implementation of SCT for SCI depends on collaborative efforts among researchers, clinicians, and patients.
Establishing standardized guidelines for clinical trials is essential for a comprehensive risk-benefit assessment and future application of SCT in SCI.